For citations:
Tsimafeyeu I.V., Baklanova O.V., Chubenko V.A., Kalpinskiy A.S., Safina S.Z., Lebedinets A.A., Petkau V.V., Olshanskaya A.S., Myslevtsev I.V., Zukov R.A. Avelumab in combination with axitinib and nivolumab in combination with ipilimumab in the first-line treatment of metastatic renal cell carcinoma: a realworld retrospective cohort study. Malignant tumours. 2024;14(4):9-17. (In Russ.) https://doi.org/10.18027/2224-5057-2024-032